Yanyang Tu

Guangdong Medical College — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

27h-index2.2kcitations85works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(15), Glioma Diagnosis and Treatment(13), Cancer-related molecular mechanisms research(13), Circular RNAs in diseases(11), Epigenetics and DNA Methylation(7)

Publications85 total

RBM7 suppresses mitochondrial dysfunction and ferroptosis by destabilizing FBXL16 mRNA to enhance Temozolomide resistance in glioblastoma
Molecular Genetics and Genomics·2025
Fucoidan in cancer therapy: from biomedical application to medicinal chemistry approach
Journal of Materials Science Materials in Medicine·2025· 1 citedOpen Access
Rewiring immune evasion in liver metastases: WNT11 as a central node — a mini review
Frontiers in Oncology·2025Open Access
A fibroblast-specific gene signature as a therapeutic target for glioblastoma developed based on the characteristics of tumor microenvironment
European journal of medical research·2025Open Access
Autophagy in doxorubicin resistance: basic concepts, therapeutic perspectives and clinical translation
Frontiers in Immunology·2025· 2 citedOpen Access
In vivo CRISPR screening identifies POU3F3 as a novel regulator of ferroptosis resistance in hepatocellular carcinoma via retinoic acid signaling
Cell Communication and Signaling·2025Open Access
ELK4 induced upregulation of HOMER3 promotes the proliferation and metastasis in glioma via Wnt/β-catenin/EMT signaling pathway
Biology Direct·2025· 3 citedOpen Access
Adoptive immune cell therapy for colorectal cancer
Frontiers in Immunology·2025· 2 citedOpen Access
Research on Precision Medicine AI Algorithm for Neuro Immune Gastrointestinal Diseases based on Quantum Biochemistry and Computational Cancer Genetics
Current Pharmaceutical Biotechnology·2025
Evaluating KLHDC8A as a biomarker for glioma: impact on survival and proliferation through the Wnt/β-catenin pathway
Discover Oncology·2024Open Access
Intelligence algorithm for the treatment of gastrointestinal diseases based on immune monitoring and neuroscience: A revolutionary tool for translational medicine
Alexandria Engineering Journal·2024Open Access
MicroRNA-mediated autophagy and drug resistance in cancer: mechanisms and therapeutic strategies
Discover Oncology·2024· 12 citedOpen Access
Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis
Frontiers in Immunology·2024· 19 citedOpen Access
Progress in building clinically relevant patient‐derived tumor xenograft models for cancer research
Animal Models and Experimental Medicine·2023· 23 citedOpen Access
The application of Aptamer in biomarker discovery
Biomarker Research·2023· 72 citedOpen Access
FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
Open Medicine·2023· 1 citedOpen Access
TGF-β Signaling Promotes Glioma Progression Through Stabilizing Sox9
Frontiers in Immunology·2021· 44 citedOpen Access
Organoids: A Platform Ready for Glioblastoma Precision Medicine?
Trends in cancer·2020· 11 cited
Gene expression profile analysis of U251 glioma cells with shRNA-mediated SOX9 knockdown.
PubMed·2019· 2 cited
Roles of pyroptosis in myocardial ischemia/reperfusion injury diseases
Journal of Advances in Health·2019· 1 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Liang Wang(12), Shiming He(12), Nan Liu(9), Zhen Wang(8), Pengxing Zhang(8), Gang Li(7), Weilin Jin(7), Jun Yuan(7), Yongsheng Zhang(7), Jianhai Zong(6), Guodong Gao(6), Yingduan Cheng(6), Yizhan Cao(5), Jianfang Fu(5), Guoqiang Fu(5), Yongsheng Zhang(5), Xingchun Gao(4), Hui Liu(4), Xinggang Mao(4), Boliang Wang(4)